Healthcare

Pro Medicus shares surged 8.3% to AUD 308.87 in morning trade, bringing its 12-month gain to 126.5%.

Pro Medicus Limited (ASX: PME),through its wholly owned U.S. subsidiary Visage Imaging, Inc., has announced the signing of a 10-year, AUD 170 million contract with UCHealth, a major not-for-profit health system based in Colorado, United States. The agreement will see the rollout of Pro …

Shares ofVitasora Health Limited (ASX: VHL)declined sharply by23% to AUD 0.03in morning trade on Wednesday following the announcement of a capital raise totallingAUD 11 million. The raise was completed through a placement to sophisticated, professional, and institutional investors, with backing from both existing and …

Tetratherix Limited (ASX:TTX),an Australian medical technology company focused on advanced biomaterial solutions, officially commenced trading on the Australian Securities Exchange (ASX) following a $25 million initial public offering (IPO). The company’s IPO was priced at AUD 2.88 per share, with 8.68 million new shares …

Microba Life Sciences Ltd (ASX:MAP), a precision microbiome company focused on developing therapeutics for chronic diseases, has announced a significant capital raise to accelerate its commercial and clinical operations in Australia and the United Kingdom.

CSL Limited (ASX:CSL) has garnered renewed investor confidence, with analysts issuingBUY recommendationsand assigning atarget price of AUD 312.99, suggesting a30.18% upside potential. This follows key developments including theFDA approval of ANDEMBRY®, a pioneering hereditary angioedema (HAE) treatment, and the appointment ofMr. Cameron Price as …

Microba Life Sciences Limited (ASX:MAP)is an Australian life sciences company focused on the development and commercialisation of microbiome testing products and services. Its technology platform supports clinicians and researchers with tools for understanding gastrointestinal health, underpinned by proprietary metagenomic sequencing capabilities